Given the impact of TRPM2 on GC survival and metastatic capabilities, our research findings suggest TRPM2 as a valuable alternative therapeutic target to improve the diagnostic of GC and TRPM2 inhibition as a potential strategy to improve its treatment. Here, TRPM2 is linked to gastric cancer.